Share on LinkedInShare on LinkedIn

ARTICLE · 11 NOVEMBER 2024

Restructuring Update: Third-Party Releases After Purdue Pharma – Solutions In Irish Law

McCann FitzGerald LLP
McCann FitzGerald LLP
Contributor
McCann FitzGerald LLP

McCann FitzGerald LLP

McCann FitzGerald LLP’s London office acts for Irish, UK and international clients on Irish law...

View firm profile
Explore more from McCann FitzGerald LLP

In Harrington v Purdue Pharma,1 the United States Supreme Court held that so-called "non-consensual third-party releases" were not permitted in restructuring plans proposed under Chapter 11 of the US Bankruptcy Code.

European UnionInsolvency/Bankruptcy/Re-Structuring

In Harrington v Purdue Pharma,1 the United States Supreme Court held that so-called "non-consensual third-party releases" were not permitted in restructuring plans proposed under Chapter 11 of the US Bankruptcy Code. A "third-party release" arises where creditors are asked to vote on a restructuring plan or scheme which not only proposes to release the debtor company (i.e. the company that has petitioned for bankruptcy or is proposing the scheme) from all liability but to also release other third parties from any associated liability.

The non-consensual nature of third-party releases has come to wider attention in the United States in recent years in connection with mass tort bankruptcies, as claims against, for example, the shareholders and officers of bankrupt companies have been excused from liability in exchange for making a financial contribution to the bankrupt estate, despite dissenting claimants objecting to the confirmation of the restructuring plan.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from